Category: Abbott Laboratories
Ferolyn Powell, the former CEO of Evalve who led it to a $410 million acquisition by Abbott, is killed in a motorbike accident in Thailand.
Former Evalve CEO Ferolyn Powell, who led the MitraClip developer to a $410 million acquisition by Abbott (NYSE:ABT), died this month in a motorbike accident in northern Thailand, her family said yesterday.
, Cantel Medical Corp.
, Clayton Dubilier Rice
, InVivo Therapeutics Corp.
, JP Morgan Chase
, NxThera Inc.
, Spectranetics Corp.
, SurModics Inc.
, Urologix Inc.
, Abbott Laboratories
Screening coronary artery disease patients using computed-tomography angiography is no better than functional testing in improving outcomes, according to a large clinical study by the National Heart, Lung & Blood Institute, plus more from the annual meeting of the American College of Cardiology.
A large clinical trial comparing computed-tomography angiography with functional testing found no benefit to clinical outcomes with CTA, which also exposes patients to large doses of radiation.
Wisconsin agrees to repay $8.1 million to the U.S. Housing & Urban Development Dept. to repay part of a $12.3 million grant for an Abbott plant that was never built.
Insulet extends its long-standing exclusive agreement with Abbott Laboratories for the integration of Abbott's FreeStyle blood-glucose monitoring technology into its OmniPod tubeless insulin-pump system.
Abbott CEO Miles White says he's not worried about the strong dollar's effect due to the company's footprint in Europe.
Here's a look at some of the top legal news stories for medical device companies this week: Johnson & Johnson settles another batch of Mentor pelvic mesh cases; J&J's $7B claim against Boston Scientific goes to the judge; Arthrex loses appeal of $33m loss to KFx